Investor Overview
AFFY (Common Stock)
Exchange Nasdaq CM
Price 14.17
Change(%) 1.323%
Volume 88,800
Data as of 05/17/12 10:11 AM ET Minimum 20 minute delay
Corporate Profile
Affymax, Inc. is a biopharmaceutical company committed to developing novel drugs to improve the treatment of serious and often life-threatening conditions. Our vision is to become a leader in the nephrology and specialty care space by delivering innovative therapeutic offerings to patients and healthcare providers.
Events & Presentations
Recent Releases
- May 7, 2012 Affymax Reports First Quarter 2012 Financial Results
- May 4, 2012 Affymax Announces Upcoming Webcasts and Conference Participation
Transfer Agent
Computershare Trust Company, Inc.
350 Indiana Street, Suite 800, Golden, Colorado 80401
(800) 962-4284
